Jul 23 2013 - PHILADELPHIA - Olfactory Biosciences Corp (OLFC) announced positive feeback from customers of NOXO Autism Aid(TM) a new and improved, all natural formulation for the Autism Spectrum. All products are immediately available http://www.noxoinfo.com/autism.html
The new NOXO Autism Aid(TM) balm, when applied topically, under the nostrils helps settle brain waves and behavioral patterns back to normal by sending scent molecules into an autistic child's system where they entirely bypass the brain-blood barrier and move directly to the brain's olfactory nerves.
One comment tells the whole story from Todd & Margaret (INKA) Inkarespite in Autstralia:
I ordered NOXO balm from your webpage and it has worked wonders. It completely stopped this attraction to odours as well as reducing many other self-stimulation behaviours. My husband and I live in Australia and have a farm which we use as a respite camp for children with Autism Spectrum Disorder. We have used NOXO for other children at the camp as well who are sensitive to certain smells. Parents purchase NOXO balm for themselves to use at home and school.
NOXO Autism Aid(TM) has the ability to detoxify and oxygenate the body, something that research has been found to help these special children by making them calmer, happier, relaxed, quieter with a feeling of well being.
NOXO is a special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds, designed to have far-reaching applications around the world
NOXO is gel, applied topically under the nostrils, specifically formulated to block the physical discomfort, retching, nausea and vomiting associated with offensive and unpleasant odors. NOXO's innovation is to control the effects of offensive and unpleasant odors at the olfactory receptor site whereas other products attempt to control bad odors at the source.
Uniquely formulated NOXO Autism Aid(TM) is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney who is a director of Olfactory Biosciences Corp and who also conducts the research for the company's products at her research facility in The Woodlands Texas.
The new NOXO Autism Aid(TM) is supplied in a tin containing over 100 applications for $ 49.95.
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples.
This company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients. Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp's unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.
Leave a comment...